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The IL-17A-Producing CD8þ T-Cell Population in
Psoriatic Lesional Skin Comprises Mucosa-Associated
Invariant T Cells and Conventional T Cells
Marcel B.M. Teunissen1, Nataliya G. Yeremenko2, Dominique L.P. Baeten2, Saskia Chielie1, Phyllis I. Spuls1,
Menno A. de Rie1, Olivier Lantz3 and Pieter C.M. Res1
IL-17A is pivotal in the etiology of psoriasis, and CD8þ T cells with the ability to produce this cytokine (Tc17 cells)
are over-represented in psoriatic lesions. Here we demonstrate that the frequency of Tc17 cells in peripheral
blood of psoriasis patients correlated with the clinical severity of the disease. Analysis of cutaneous-associated
lymphocyte antigen expression showed that the blood Tc17 population contains a significantly higher proportion
of cells with skin-homing potential compared with the CD8þ T-cell population lacking IL-17A/IL-22 expression. IL-
17A-producing CD8þ T cells in blood have previously been reported to belong mainly to the mucosa-associated
invariant T-cell (MAIT cell) lineage characterized by TCR Va7.2 chain, CD161, IL-18Ra, and multidrug transporter
ABCB1 expression. We demonstrate the presence of CD8þ MAIT cells in the dermis and epidermis of psoriatic
plaques, as well as healthy skin; however, IL-17A-producing CD8þ MAIT cells were predominantly found in
psoriatic skin. Notably, we observed IL-17A production in a large proportion of psoriatic plaque–derived CD8þ T
cells devoid of MAIT cell characteristics, likely representing conventional CD8þ T cells. In conclusion, we provide
supporting evidence that implicates Tc17 cells in the pathogenesis of psoriasis and describe the presence of
innate CD8þ MAIT cells in psoriatic lesions as an alternative source of IL-17A.
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INTRODUCTION
Recent investigations suggest an important role in the patho-
genesis of psoriasis for IL-17A produced by CD4þ T helper
cells (Th cells) and CD8þ cytotoxic T cells, termed Th17 and
Tc17 cells, respectively, which may also express IL-22. The
level of IL-17A message RNA is elevated in psoriatic skin, and
keratinocytes stimulated in vitro with IL-17A share many
features with keratinocytes in psoriatic plaques, such as
increased proliferation and enhanced production of antimi-
crobial peptides and inflammatory cytokines (Teunissen
et al., 1998; Nograles et al., 2008). IL-23, important for the
activation and survival of IL-17A-producing T cells, is also
expressed at increased levels by dendritic cells, macrophages,
and keratinocytes in psoriatic skin (Lee et al., 2004; Piskin
et al., 2006). Genetic polymorphisms in the IL23A, IL12B, and
IL23R genes that code for the unique IL-23p19 chain, the
common IL-12/IL-23 p40 chain, and one of the IL-23 receptor
subunits, respectively, are associated with psoriasis, further
implicating the importance of the IL-23/IL-17A axis in psoriasis
(Capon et al., 2007; Cargill et al., 2007; Nair et al., 2009).
A neutralizing antibody against the IL-12/IL-23 p40 subunit is
currently applied as an efficacious drug for treating psoriasis
(Leonardi et al., 2008; Strober et al., 2011), and, in addition,
phase 2 studies involving therapy with anti-IL-17A and anti-IL-
17R showed improvement of psoriasis (Hueber et al., 2010;
Leonardi et al., 2012; Papp et al., 2012).
A number of observations indicate that CD8þ T cells are
key elements in the etiology of psoriasis. The major histo-
compatibility complex (MHC) class I allele HLA-Cw*0602 is
by far the strongest risk determinant for developing psoriasis
(Mallon et al., 1999; Nair et al., 2006), suggesting that the
corresponding MHC class I molecule may have a critical role
in peptide presentation to pathogenic CD8þ T cells.
Approximately two-thirds of psoriasis patients carry the HLA-
Cw*0602 allele, while present in only 10–15% of the general
population (Gudjonsson et al., 2004). There is a close
correlation between the frequency of skin-homing
cutaneous-associated lymphocyte antigen (CLA)þCD8þ T
cells in blood and the severity of psoriasis, as well as
between perforin expression (a CD8þ T cell-related
molecule) and disease severity (Sigmundsdottir et al., 2001;
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Prpic et al., 2007). The frequency of Tc17, but not of Th17
cells, is increased in psoriatic skin in comparison with normal
skin (Ortega et al., 2009; Res et al., 2010), suggesting that
Tc17 cells may have locally expanded in response to
psoriasis-associated (auto)antigens in a MHC class I–
restricted manner, as part of an uncontrolled adaptive immune
response. Intriguingly and possibly in contradiction with this
presumption, it has been reported that the vast majority of IL-
17A-producing CD8þ T cells in peripheral blood are mucosa-
associated invariant T cells (MAIT cells) (Dusseaux et al.,
2011), which belong to the innate immune system and use a
semi-invariant TCR to recognize bacterial ligands in the
context of MR1 (Treiner et al., 2003; Huang et al., 2009; Le
Bourhis L. et al., 2010), a MHC class I-like antigen-presenting
molecule. The typical invariant TCR a-chain on MAIT cells
consists of a variable region 7.2 segment associated with a
joining region 33 segment (Va7.2–Ja33) (Tilloy et al., 1999).
MAIT cells further coexpress CD161 (high), IL-18Ra, and the
multidrug transporter ABCB1, enabling efficient efflux of
xenobiotics (Le Bourhis et al., 2011). MAIT cells display an
effector-memory phenotype and constitute 1–10% and less
than 0.1% of human peripheral blood CD8þ T cells and
CD4þ T cells, respectively (Dusseaux et al., 2011). More than
90% of the human CD3þCD161þ þVa7.2þ MAIT cells
express CD8, either as a homodimer of CD8a chains or as a
heterodimer of CD8a and -b chains in approximately similar
proportions (Walker et al., 2012). To date, there is no
information about the presence of MAIT cells in the healthy
and diseased human skin and whether the Tc17 cells in
psoriatic lesions represent MAIT cells.
This study was aimed to determine the possible association
between clinical severity of psoriasis and the relative propor-
tions of IL-17A-, IFN-g-, or IL-22-producing T cells in
peripheral blood. Further, we studied the skin tropism of these
T-cell subsets by analyzing the expression of skin-homing
molecule CLA. Finally, we investigated whether the IL-17A-
producing CD8þ T cells in psoriatic lesional skin belong to
the MAIT cell lineage.
RESULTS
Frequency of IL-17A-producing CD8þ T cells in blood from
psoriasis patients correlates with Psoriasis Area and Severity
Index
In search for the possible association of clinical severity with
the relative proportions of IL-17A-, IFN-g-, or IL-22-producing
T cells in peripheral blood, we assessed the Psoriasis Area and
Severity Index (PASI) of fifteen psoriasis patients and deter-
mined their cytokine expression in T cells upon short-term
stimulation. In the CD8þ T-cell population, we found a mean
of 0.26±0.20% IL-17A producers, 36.1±14.3% IFN-g pro-
ducers, and 0.24±0.20% IL-22 producers, whereas in the
CD4þ T-cell population these frequencies were 1.1±0.72%,
11.3±5.0%, and 1.2±0.70%, respectively (Figure 1). Statis-
tical analysis revealed that only the frequencies of IL-17A-
producing CD8þ T cells significantly correlated with the PASI
(Figure 1). Although a similar trend was found for IFN-g-
producing CD8þ T cells, it did not reach significance. These
results support the view that CD8þ T cells, in particular the IL-
17A-producing ones, may have a role in the pathogenesis of
psoriasis.
IL-17A- and IL-22-producing blood T-cell populations show
increased frequency of CLA expressing cells
To examine whether blood IL-17A-producing T cells can
home in the skin and might be implicated in psoriasis, we
determined the expression of CLA. We found that a
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Figure 1. Frequency of IL-17A-producing CD8þ T cells in blood of psoriasis patients correlates with Psoriasis Area and Severity Index (PASI). CD8þ and CD4þ
T cells in peripheral blood of psoriasis patients were analyzed by multiparameter flow cytometry for their expression of IL-17A, IL-22, and IFN-g upon short-term
stimulation in vitro. The percentages of CD8þ (top row) or CD4þ (bottom row) T cells expressing IL-17A, IL-22, and IFN-g, respectively, are plotted against the
patient’s PASI. The IL-17A and IFN-g data shown are the total percentages irrespective of the coexpression of other cytokines, whereas the percentage of IL-22 SP
(single positive) refers to cells that lacked coexpression of both IL-17A and IFN-g. The square symbols represent the mean percentage±SD. Data are from 12–15
independent experiments with 15 different donors.
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significantly higher frequency of IL-17A-producing T cells in
blood from psoriasis patients showed CLA expression (espe-
cially those with high IL-17A expression) compared with T
cells without IL-17A expression, not only in the CD8þ T-cell
population (31.0±11.5% versus 3.7±3.3%; Po0.01), but
also in the CD4þ T-cell population (16.0±10.1% versus
3.7±2.9%; Po0.05) (Figure 2a). The IL-22-producing
CD8þ and CD4þ T cells also contained significantly higher
frequencies of CLAþ T cells compared with those lacking IL-
22 expression (CD8þ T cells 27.1±7.7% versus 3.1%±1.7,
Po0.01 and CD4þ T cells 12.4±1.4% versus 3.8±1.8%,
Po0.001), whereas this feature was not observed for IFN-g
producers (data not shown). Increased levels of CLAþ T cells
within IL-17A- and IL-22-producing blood CD8þ and CD4þ
T cells were not typical for psoriasis, but were also observed in
healthy individuals (Figure 2b and c). Furthermore, the
population of IL-17A and IL-22 double-producing T cells
was also enriched for CLAþ T cells (data not shown). The
IL-17A- and IL-22-producing T cells represent a small propor-
tion of the total CD4þ and CD8þ T-cell populations. CLAþ
CD8þ IL-17-producing T cells constituted 0.88±0.34% of the
total CLAþCD8þ T-cell population, whereas CLAþCD4þ
IL-17-producing T cells constituted 3.65±1.44% of the total
CLAþCD4þ T-cell population. Similarly, for the CLAþ IL-22-
producing CD8þ and CD4þ T cells, the frequencies were
1.84±1.02% and 3.71±1.12%, respectively.
As IL-17 and CLA positivity is almost exclusively restricted
to CD45ROþ memory T cells, we performed experiments
(n¼ 3) to find out whether the IL-17þ T-cell populations are
still enriched for CLAþ cells when excluding the CD45RO–
T cells from our analysis. As concerns the CD8þ T cells, the
frequencies of CLAþ T cells in the IL-17Aþ and IL-17A–
populations only marginally changed upon gating on
CD45ROþ cells, and as a result the CLAþ /CLA– ratios
remained the same (data not shown). As concerns the
CD4þ T cells, we consistently found that the percentage of
CLAþ cells (and thus the CLAþ /CLA– ratio) increased only in
the IL-17A– population (approximately 2-fold), when gating on
CD45ROþ T cells, yet this ratio was still markedly lower than
in the IL-17Aþ population (data not shown). In sum, our
results indicate that the population of blood T cells with the
capacity to produce IL-17A and/or IL-22 shows enhanced skin
tropism.
The presence of MAIT cells in psoriatic lesional skin and healthy
human skin
Because the majority of the IL-17A-producing CD8þ T cells in
blood are MAIT cells (Dusseaux et al., 2011) and IL-17A-
producing CD8þ T cells are over-represented in psoriatic
lesional skin (Res et al., 2010), we wondered whether IL-17A-
producing CD8þ T cells in psoriatic lesions belong to the
MAIT cell lineage. We found that 13.4±12.7% (range
1.9–27.9%) of the CD8þ T cells from psoriatic dermis
showed a high expression of CD161, carried the IL-18Ra
subunit, and displayed the invariant TCR Va7.2 chain
(detected by the monoclonal antibody 3C10), altogether
typifying MAIT cells (Figure 3a). Similarly, 5.1±3.0% (range
1.5–9.3%) of the CD8þ T cells from psoriatic epidermis
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Figure 2. IL-17Aþ and IL-22þ T cells in blood from psoriasis patients and
healthy individuals show increased frequency of cutaneous-associated
lymphocyte antigen (CLA) compared with IL-17A– and IL-22– T cells.
Peripheral blood T cells were short-term stimulated, after which the CD8þ and
CD4þ T cells were analyzed for IL-17A and IL-22 production and CLA
expression by six-color flow cytometry. The populations of IL-17A- and IL-22-
producing CD8þ and CD4þ T cells contain a considerable higher frequency of
CLA-expressing cells as compared with the populations that lack production of
these cytokines. (a) Analysis of skin-homing receptor CLA expression and IL-
17A and IL-22 production in T cells of a representative psoriasis patient.
Summary of the CLAþ /CLA– ratios in (b) IL-17A- and IL-22-producing CD8þ
and CD4þ T cells (ratio of the percentage in the upper right quadrant versus
percentage in bottom right quadrant) or nonproducing T cells (ratio of the
percentage in the upper left quadrant versus percentage in bottom left quadrant)
from five different psoriasis patients and five healthy donors. **Po0.01.
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appeared to be MAIT cells (Figure 3a). We were able to
expand the MAIT cells along with the total T-cell population
by nonspecific polyclonal stimulation (Figure 3a). The pre-
sence of MAIT cells in skin is not unique to psoriatic skin, as
part of the CD8þ T cells from healthy dermis (4.6±4.0%,
range 0.4–10.5%) and epidermis (11.6±11.0%, range 2.2–
19.6%) also expressed the MAIT cell phenotype CD161hiTCR-
Va7.2þ IL-18Raþ (Figure 3b). The percentages of MAIT cells
in psoriatic and healthy skin were not significantly different.
Of note, the skin T cells analyzed in this study were obtained
by spontaneous migration from skin explants, but the compo-
sition of the skin cell suspension might vary to some extent
when applying other processing methods (e.g., enzyme
digestion of skin tissue). Detection of the invariant TCR
Va7.2–JVa33 transcripts in the bulk T-cell cultures provided
further proof for the presence of MAIT cells in psoriatic skin
(Figure 3c). CD8þ MAIT cells derived from psoriatic plaque
skin were capable of effluxing the dye rhodamine, showing
their functional expression of the multidrug transporter ABCB1
(Figure 3d).
As the expression of skin-tropic chemokine receptors is
essential to enable skin accumulation by cells from the
peripheral blood, we determined the expression of several
skin-homing receptors on peripheral blood CD8þ MAIT cells
in comparison with conventional CD8þ T cells. As shown in
Figure 3e, we found that the MAIT cell population contained
a slightly, but not significantly, higher frequency of CLAþ
T cells than the CD8þ T-cell population (a mean of
6.6±2.6% versus 4.7±3.4%). Remarkably, a significantly
higher portion of MAIT cells displayed the expression of
CCR6 (28.8±7.9% versus 2.4±1.3%), whereas the expres-
sion of CCR7 was virtually absent (0.3±0.1% versus
25.3±16.6%). Many MAIT cells expressed CD49a
(25.4±24.4%) and to a lesser extent CCR10 (5.5±5.3%)
and CD103 (4.3±1.1%), but these frequencies were very
similar for conventional CD8þ T cells (21.7±12.5%;
5.6±6.0% and 4.0±1.6%). In sum, these data indicate that
MAIT cells are common residents in human skin and may
originate from blood CD8þ MAIT cell populations, which
express receptors related to skin homing.
IL-17A-producing CD8þ T cells in psoriatic lesions comprises
MAIT cells and conventional T cells
Next we examined whether the IL-17A-producing CD8þ
T cells from psoriatic lesions are part of the MAIT cell lineage
or represent conventional T cells. Dependent on the number
of cells that had migrated out of skin fragments, cytokine
production was either directly assayed or cells were expanded
one cycle to yield sufficient cells for cytokine expression
analysis. The T cells were either directly stimulated (Figure 4a)
or first sorted into phenotypic distinct subsets before stimula-
tion (Figure 4b). With both approaches, we observed IL-17A
expression in TCR-Va7.2þCD161þ MAIT cells, as well as in
conventional T-cell subsets within the population of psoriatic
plaque–derived CD8þ lymphocytes. Within both TCR-
Va7.2þ and TCR-Va7.2– T-cell populations, the highest
percentages of IL-17A producers were consistently found in
CD161þ T cells. The MAIT cells contained a relatively lower
percentage of IL-22 producers than other CD8þ T-cell subsets.
In summary, the IL-17A-producing CD8þ T-cell population in
psoriatic lesions comprises MAIT cells and conventional
T cells, whereas IL-17A-producing CD8þ T cells are almost
absent in normal skin (data not shown and Res et al., 2010).
Tc17 cells within peripheral blood encompass almost all
MAIT cells (Dusseaux et al., 2011), which is clearly different
from lesional psoriatic skin where Tc17 cells are more evenly
distributed among MAIT cells and conventional CD8þ T cells
(Figure 4a and b).
MAIT cell and conventional Tc17 clones from psoriatic lesional
skin
To find further support for our observation that Tc17 cells from
lesional psoriatic skin comprise both MAIT cells and conven-
tional CD8þ T cells, we generated T-cell clones from CD8þ
T cells expressing CD161, which has been put forward as a
marker that identifies most closely those T cells with IL-17A
production (Maggi et al., 2010). We generated from one
psoriasis patient 28 dermal and 10 epidermal TCRab CD8þ
T-cell clones, of which 25 dermal and 7 epidermal T-cell
clones produced IL-17A and IL-22 and in many cases also
IFN-g (data not shown). Only few T-cell clones of this panel
produced IFN-g in the absence of IL-17A and IL-22, indicating
that the CD8þCD161þ T cells were indeed enriched for
Tc17 cells. Only one Tc17 cell clone displayed a MAIT cell
phenotype, whereas all other Tc17 clones represented
conventional CD8þ T cells. This MAIT cell clone was the
only clone that expressed TCR Va7.2-Ja33 mRNA (Figure 3c)
and was recognized by the TCRVa7.2 antibody (Figure 5). In
comparison with a second MAIT cell clone generated from
blood of another psoriasis patient, both MAIT cell clones
displayed IL-17 expression and the ability to efflux rhodamine
dye (Figure 5), but showed differential expression of IL-22
and IFN-g. Our analysis at the clonal level also clearly
demonstrates the coexistence of MAIT cells and conventional
Tc17 cells in psoriatic lesional skin.
DISCUSSION
In this study, we provide support for the involvement of
IL-17A-producing CD8þ T cells in the pathogenesis of
psoriasis. First, we demonstrated that the Tc17 cell frequency
in blood of psoriasis patients significantly correlates with the
clinical severity. Remarkably, and perhaps unexpectedly,
there was no correlation between clinical severity and the
percentage of Th17 cells, which are generally believed to have
a major role in psoriasis (Elloso et al., 2012). Second, based on
the expression of CLA, we show that the population of Tc17
cells in blood has a relatively increased tropism for skin, in
particular those cells with a high level of IL-17A production.
Our observations fit with earlier reports showing correlation
between the frequency of blood CLAþCD8þ T cells and
severity of psoriasis (Sigmundsdottir et al., 2001) and showing
overrepresentation of Tc17 cells in lesional psoriatic skin (Res
et al., 2010). CD8þ MAIT cells also express CLA and several
other receptors that have been implicated in the migration of
CD8þ T cells into the skin (Conrad et al., 2007; Gunther
et al., 2012), such as CD49a, CCR6, CCR10, CD103 (present
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study), and CXCR6 (Dusseaux et al., 2011), indicative of the
potential of CD8þ MAIT cells to accumulate in the skin.
Third, although we describe MAIT cells as common residents
in normal skin, IL-17A-producing CD8þ MAIT cells were
found predominantly in psoriatic lesional skin. Finally, we
show that, in contrast to the situation in blood, IL-17A-
producing CD8þ T cells from lesional skin include a large
portion of conventional CD8þ T cells, which may represent
disease-related CD8þ T cells. In addition, our results confirm
our earlier observation that psoriatic plaque epidermis
contains a higher proportion of IL-17A-producing CD8þ T
cells than plaque dermis, whereas normal skin from healthy
donors is almost devoid of Tc17 cells (Res et al., 2010).
The increased numbers of Tc17 cells in psoriatic plaques
may be explained by the selective advantage these cells have
to enter the skin. On the other hand, part of the Tc17 cells in
the lesional infiltrate may have expanded upon local activa-
tion, after recognition of (auto)antigens in the context of MHC
class I, with HLA-Cw*0602 as the most likely restriction
element in a large part of the psoriasis patients. In this view,
the Tc17 cell response within the lesion would represent an
adaptive immune response by conventional CD8þ T cells—
rather than an innate immune response of CD8þ MAIT cells,
which recognize antigens presented by MR1. This proposition
would be in concordance with our finding that many IL-17A-
producing CD8þ T cells present in psoriatic plaques do not
express the invariant TCR Va7.2-Ja33 chain that marks MAIT
cells. Although blood Tc17 cells almost all belong to the MAIT
cell lineage (Dusseaux et al., 2011), we observed that psoriatic
lesions contained considerable proportions of conventional
Tc17 cells. Further, all IL-17A-producing TCRabþ T-cell
clones turned out to be conventional Tc17 cells, except for
one MAIT cell clone. However, it cannot be ruled out that this
low yield of MAIT cell clones just reflects possible difference
in the potential to expand CD8þ MAIT cells and conventional
CD8þ T cells at the single-cell level.
Patients with hepatitis C infection have Tc17 cells that
recognize self-antigens from apoptotic cells presented by HLA
molecules (Franceschini et al., 2012), clearly showing that
IL-17A production is present in conventional TCRabþCD8þ
T cells. If autoreactive HLA-restricted Tc17 cells exist in
psoriasis, they are presumably present predominantly in the
inflamed sites. We have shown that IL-17A-producing MAIT
cells coexist with conventional Tc17 cells. Although MAIT
cells appear to recognize only bacterial and yeast antigens in
the context of MR1, it cannot be excluded that some MAIT
cells also respond to peptides presented by HLA peptides and
thus behave as conventional T cells. Indeed, Havenith et al.
(2012) have shown that tetramers, consisting of influenza virus
or cytomegalovirus-derived peptides coupled to HLA-A2
molecules, bind to a minor fraction of CD8þCD161hiIL-
18Raþ T cells, which could be expanded through stimu-
lation with antigen-presenting cells and relevant peptides.
However, as Va7.2 expression on the Tetþ cells was not
determined in these experiments, the relationship of the
antiviral CD161hi IL-18Raþ CD8 T cells with MAIT cells is
not clear. The presence of MAIT cells in psoriatic lesions could
be instrumental in the disease or a nonspecific migration to an
inflamed tissue. Study of other skin diseases with similar
inflammation would help decipher this issue.
Our observation that the blood Tc17 cell frequency is
correlated with disease activity implicates that Tc17 cells are
relatively more abundant in blood of patients with severe
psoriasis. The cause of this increase in blood Tc17 cells is
unknown. On one hand, severe psoriasis may be accompa-
nied by excessive local proliferation of Tc17 cells, which
subsequently leave the skin through the lymphatic system and
finally end up in the blood circulation. However, according to
a recently proposed concept, a population of long-lived
nonrecirculating CD8þ T cells with self-renewal capacity
would reside in the skin, providing long-term protective
immunity (Gebhardt et al., 2009; Gebhardt et al., 2011;
Jiang et al., 2012). At present, it remains unclear whether
this skin-resident CD8þ T-cell population comprises Tc17
cells and/or CD8þ MAIT cells. On the other hand, many
blood Tc17 cells may have originated from lymphoid organs,
in particular the tonsils, as throat infection with Streptococci
often precedes or exacerbates psoriasis (Sigurdardottir et al.,
2013). Tc17 cells expanding in response to streptococcal
antigens in the inflamed tonsils represent perhaps the principal
source of the blood Tc17 cells observed in severe psoriasis.
Consistent with this, it has been shown that there is a
correlation in psoriasis patients between the percentages
of CLAþCD8þ T cells in blood and tonsils, which produce
IL-17A upon stimulation with streptococcal antigens
(Thorleifsdottir et al., 2012). Interestingly, psoriasis patient
blood–derived CLAþ T cells, but not CLA– T cells, when
cocultured with autologous epidermal cells, showed IL-17A
and IL-22 production, only if streptococcal extract was added
to the culture (Ferran et al., 2013). Furthermore, stimulation of
Figure 3. The presence of mucosa-associated invariant T (MAIT) cells in psoriatic lesional skin and healthy skin. Migratory cells from dermal and epidermal
tissue from psoriasis patients or normal individuals were collected after culture, stimulated, and analyzed by multiparameter flow cytometry. (a) A clear
population of MAIT cells, identified as TCR Va7.2þ IL-18Rþ cells within the CD8þCD161þ fraction of lymphocytes, is present in both dermal and epidermal
cell suspensions (panels left) and could be maintained and propagated in vitro (panels right). Shown data are from one psoriasis patient and representative of five
independent experiments. (b) MAIT cells are present in the dermal and epidermal cell suspensions from one normal individual, being representative of three
healthy donors. (c) Detection of MAIT cell-marker Va7.2-Ja33 mRNA in bulk T-cell populations and CD8þ T-cell clones derived from the dermis and epidermis
of one psoriasis patient. Data are depicted as arbitrary units relative to the expression of housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). (d) Capacity of psoriatic plaque–derived CD8þ epidermal MAIT cells (TCR-Va7.2þCD161þ ) and other indicated CD8þ T-cell subsets to efflux
rhodamine by the multidrug transporter ABCB1. Expression of a functional transporter can be appreciated as a drop of the rhodamine signal in preloaded
cells toward the unloaded medium control as compared with preloaded cells incubated in the presence of cyclosporine A, which blocks the multidrug
transporter. (e) Expression of skin tropism–related molecules by peripheral blood CD8þ MAIT cells and conventional CD8þ T cells. Data are representative
of seven independent experiments with different donors.
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blood mononuclear cells with streptococcal antigens also
induces the expression of CLA (Leung et al., 1995), thereby
facilitating streptococci-specific T cells to enter the skin.
Preactivated T cells have a lower threshold of reactivation,
and therefore, once CLAþ streptococci-primed Tc17 cells
have entered the skin, they may be more prone to cross-react
with local self-antigens, such as keratinocyte-derived keratins
that have been shown to share homologous epitopes
with streptococcal antigens (Sigmundsdottir et al., 1997;
Gudmundsdottir et al., 1999; Johnston et al., 2004; Shen
et al., 2005).
IL-17A is a key cytokine in psoriasis, as therapy by biologi-
cally targeting IL-17A or its receptor, IL-17RA, has a significant
clinical effect (Hueber et al., 2010; Leonardi et al., 2012; Papp
et al., 2012). Hence, it is important to know all potential IL-17A
sources in psoriatic skin as they might be involved in the
pathological mechanism of the disease. Here, we identify that
MAIT cells in psoriatic skin represent an additional source of IL-
17A. MAIT cells belong to the group of innate T cells that, upon
activation, are able to rapidly secrete effector molecules,
including IL-17A, but also IFN-g and tumor necrosis factor-a
(Dusseaux et al., 2011), leading to strong inflammatory
responses. MAIT cells respond to compounds of a large
variety of microorganisms that are presented by the MR1
molecule, which is ubiquitously expressed—among others by
dendritic cells (DCs) and epithelial cells, such as keratinocytes.
DCs and keratinocytes in psoriatic skin show increased levels of
IL-23 (Lee et al., 2004; Piskin et al., 2006), which promotes IL-
17A production. In addition, MAIT cell activation is modulated
by CD161 triggering via its ligand LLT1, which is present on
TLR-activated DCs (Germain et al., 2011), and increased
numbers of activated CD11cþ DCs are present in psoriasis
lesions (Zaba et al., 2009; Teunissen et al., 2012). Although
elements (such as MR1, IL-23, LLT1) required to stimulate MAIT
cells are locally present, it is currently unclear whether any
MAIT cells become activated within psoriatic skin and whether
microbial agent(s) are involved in their activation. An interesting
candidate would be streptococcal antigens, as outlined above;
however, it has been reported that MAIT cells do not respond to
Streptococci (Le Bourhis et al., 2010). As there is no clear
candidate microbial antigen yet, it is difficult to indicate
whether MAIT cells become activated and are involved in the
pathogenesis of psoriasis. Their activation may also just be a
consequence of the ongoing inflammation (for example, MAIT
cells can be activated by a cytokine combination of IL-12 plus
IL-18 in a TCR-independent manner, (Ussher et al., 2014)).
Irrespective of the answer, by means of secretion of large
quantities of effector molecules, MAIT cells may contribute to
the perpetuation of the inflammation.
In conclusion, evidence for a central role of CD8þ T cells
in psoriasis is accumulating and nicely fits with the fact that
HLA-Cw*0602 is the strongest risk allele for developing this
inflammatory skin disease. Here we provide additional evi-
dence that implicates IL-17A-producing CD8þ T cells in the
pathogenesis of psoriasis. Remarkably, although normal skin is
almost devoid of these T cells, psoriatic lesions (in particular in
the epidermis) contains large proportions of Tc17 cells con-
sisting of innate CD8þ MAIT cells and conventional CD8þ T
cells. Combined analysis of the antigen recognition, HLA
restriction, and TCR usage of MAIT cells and conventional
Tc17 cells derived from skin and peripheral blood may
help unravel the respective involvement of these two cell
types in the disease. Whether and how both populations of
Tc17 cells become activated inside plaque skin to release their
pathogenic cytokine content remains the topic of future
investigations.
MATERIALS AND METHODS
Patients
Adult patients (10 female/19 male, mean age 46.5 years; range
20–69) with active psoriasis vulgaris lesions who visited the Depart-
ment of Dermatology at the Academic Medical Center in Amsterdam
and fulfilled the inclusion criteria were asked to participate in this
study. The study was reviewed and approved by the institutional
Medical Ethical Committee and was conducted according to the
Declaration of Helsinki principles. All patients gave their written
informed consent before enrollment. All patients refrained from any
systemic therapy or phototherapy for at least 4 weeks before
participation, and topical treatments for psoriasis were not allowed
14 days before baseline. After determination of their PASI (mean 13.1;
range 2.3–25.2), the patients donated 4-mm punch biopsies from an
active plaque, and blood was sampled via venipuncture. Normal
adult skin and blood samples of the same donor were obtained from
healthy subjects undergoing plastic surgery of the breast or abdomen
after informed consent.
Isolation of cells from peripheral blood and skin
Blood mononuclear cells were isolated with lymphocyte separation
medium LSM 1077 (PAA Laboratories, Pasching, Austria). Skin
samples were incubated overnight at 4 1C in phosphate-buffered
saline with 0.3% dispase II (Roche Diagnostics, Almere, the
Netherlands). Next, the dermis and epidermis of the biopsies were
separated and cultured for 6–7 days in Iscove’s modified dulbecco’s
media (PAA Laboratories) with 10% normal human AB serum (NHS;
Lonza, Breda, the Netherlands) to allow spontaneous migration of
cells from the tissue fragments. Dermal and epidermal tissues from
normal skin were cultured in Iscove’s modified dulbecco’s media
with 10% fetal calf serum (Gibco, Life Technologies, Bleiswijk, the
Netherlands).
Generation of T-cell lines and clones
T-cell lines and clones were generated by stimulation with PHA, IL-2,
and feeder-cell mix, as described before (Res et al., 2010).
Flow cytometry analysis
The following antibodies were used: FITC-conjugated anti-CLA, APC-
conjugated anti-CD8, APC-conjugated anti-CD161, FITC-conjugated
anti-CD45RO, PE-conjugated anti-CCR7 (all from BD Biosciences,
Mountain View, CA); and PE-conjugated anti-IL-18Ra, PerCP-con-
jugated anti-CD3, APC-Cy7 or PE-Cy7-conjugated anti-CD4, FITC or
APC-Cy7-conjugated anti-CD8, PE-conjugated anti-CD49a, PE-con-
jugated anti-CD103 (all from BioLegend, San Diego, CA), PE-
conjugated anti-CCR6 and PE-conjugated anti-CCR10 (R&D Systems,
Abingdon, UK), biotin-conjugated anti-TCR Va7.2 chain (clone 3C10)
(Martin et al., 2009) using PE-Cy7-conjugated streptavidin
(BioLegend) as second step.
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Cytokine production was induced in T cells by stimulation for
5 hours with 100 ng ml 1 PMA (Sigma-Aldrich, St Louis, MO)
and 1mg ml 1 ionomycin (Sigma-Aldrich), and for the last 4 hours
in the presence of GolgiPlug (BD Biosciences). After fixation
with 4% formaldehyde in phosphate-buffered saline for 10 minutes,
cells were stained for cell surface markers and intracellular cytokines,
using PE, PerCP5.5, or Alexa Fluor 647-conjugated anti-IL-17A
(eBioscience, San Diego, CA), PE-conjugated anti-IL-22 (R&D Sys-
tems Europe, Abingdon, UK), and FITC-conjugated anti-IFN-g (BD
Biosciences) for 30 minutes (Res et al., 2010). Acquisition was
performed with a FACS Aria and analysis with the FlowJo software
(TreeStar, Ashland, OR).
Rhodamine efflux assay
Cells were loaded in RPMI 1640 (PAA Laboratories) with 10% fetal
calf serum, containing 0.1mg ml 1 rhodamine (Rh123; Sigma-
Aldrich), in the presence or absence of 3 mg ml 1 cyclosporine A
(Sigma-Aldrich), for 30 minutes at 37 1C. After extensive washing,
efflux of rhodamine was allowed for 30 minutes at 37 1C in the
presence or absence of cyclosporine A and analyzed by flow
cytometry.
Real-time quantitative PCR
PCR was performed as described before (Yeremenko et al., 2013).
In short, total RNA was extracted with a MiniPrep RNA kit (Sigma-
Aldrich) and reverse-transcribed using the RevertAid H Minus First-
Strand cDNA synthesis kit (Fermentas, Fisher Scientific, Landsmeer,
The Netherlands). Specific PCR primers and TagMan probe for human
TCR Va7.2–JVa33 were designed by Custom TaqMan Assay Design
Tool (Applied Biosystems, Life Technologies Europe, Bleiswijk,
The Netherlands): sense primer, 50-TTCCTTAGTCGGTCTAAAGGGT
ACA-30, antisense primer, 50-ACAGAGGTAAGAGGCAGAGTCTTTC
A-30 probe, 50-CCTTTTGAAGGAGCTCC-30. PCR was performed
using glyceraldehyde-3-phosphate dehydrogenase (4310884E,
Applied Biosystems) in duplex assay format (duplex Va7.2–JVa33-
FAM and GAPDH-VIC probes) according to the manufacturer’s
protocol (Applied Biosystems). All samples were normalized to the
expression of glyceraldehyde-3-phosphate dehydrogenase and results
are presented in arbitrary units.
Statistical analysis
Statistical analysis was done with GraphPad Prism (GraphPad Soft-
ware, La Jolla, CA) using the paired Student’s t-test and Spearman
correlation test, taking Po0.05 as significant.
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